GlassScriptPhysician profile
Tanya Bhattacharya
NPI 1902284078
$4,524.50
in general payments reported to CMS, 2019-2025
20 companies · $2,149 in 2025
The $2,149 reported for 2025 was more than what 77% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.92 · 2020: $464 · 2021: $204 · 2022: $488 · 2023: $545 · 2024: $586 · 2025: $2,149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,971 · Education: $309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,971.27 |
| Education | $308.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,166.70 | 2019-2025 | Skyrizi |
| Regeneron Healthcare Solutions, INC. | $654.38 | 2020-2025 | Dupixent, Libtayo |
| Janssen Biotech, INC. | $580.02 | 2021-2025 | Tremfya, Simponi Aria, Stelara |
| Novartis Pharmaceuticals Corporation | $490.52 | 2019-2025 | |
| Lilly USA, LLC | $461.41 | 2020-2025 | Taltz, Ebglyss, Olumiant |
| Genzyme Corporation | $365.06 | 2020-2025 | |
| Dermavant Sciences, INC. | $135.37 | 2022-2024 | Vtama |
| Pfizer INC. | $105.62 | 2023-2025 | |
| Incyte Corporation | $102.63 | 2024-2025 | Opzelura |
| Leo Pharma INC. | $94.67 | 2023-2025 | Adbry |
| Ucb, INC. | $73.10 | 2019-2025 | Bimzelx |
| Organon LLC | $51.48 | 2025 | Vtama |
| Dermira, INC. | $49.34 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.25 | 2023-2024 | Spevigo, Cyltezo |
| Amgen INC. | $36.55 | 2025 | Otezla |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $34.97 | 2025 | Klisyri |
| Botanix Sb INC | $25.67 | 2025 | Sofdra |
| Vyne Pharmaceuticals INC. | $23.70 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.94 | 2020 | |
| Galderma Laboratories, L.P. | $15.12 | 2025 | Aklief |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tanya Bhattacharya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.